Shanghai Fosun Pharmaceutical (02196): Multiple products newly included in the National Reimbursement Drug List

date
18:18 15/11/2026
avatar
GMT Eight
Shanghai Fosun Pharmaceutical (02196) announced that, according to the "National Drug List for Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance (2026)" issued on November 14, 2026 by the National Healthcare Security Administration and the Ministry of Human Resources and Social Security, multiple marketed products of the group have been included for the first time, had remarks-related information adjusted, or been transferred from negotiated drugs to routine list management.
Shanghai Fosun Pharmaceutical (02196) announced that, according to the "National Drug List for Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance (2026)" released on November 14, 2026 by the National Healthcare Security Administration and the Ministry of Human Resources and Social Security, multiple marketed products of the Group have been included for the first time, have had remarks-related information adjusted, or have been transferred from negotiated drugs to routine list management. I. Main varieties newly included or with remarks-related information adjusted II. Main varieties transferred from negotiated drugs to routine list management